StockData
Elanco Animal Health Inc logo

Elanco Animal Health Inc (ELAN) stock

ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$26.70+0.85 (+3.29%)

Close on Nov 18, 2026Market cap $13.34BP/E –Yield –

Elanco Animal Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Elanco Animal Health's operating cash flow for the twelve months ending Jun 30, 2026 was $617.00M, up 7.9% year over year. For fiscal 2025 it was $560.00M, up 3.5% from the year before. The highest annual figure on record is $560.00M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$560.00M+3.5%
FY2024Dec 31, 2024$541.00M+99.6%
FY2023Dec 31, 2023$271.00M-40.0%
FY2022Dec 31, 2022$452.00M-6.4%
FY2021Dec 31, 2021$483.00M–
FY2020Dec 31, 2020-$41.00M-118.3%
FY2019Dec 31, 2019$224.00M-54.0%
FY2018Dec 31, 2018$487.30M+180.4%
FY2017Dec 31, 2017$173.80M+11.5%
FY2016Dec 31, 2016$155.90M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$277.00M+16.9%
Q1 FY2026Mar 31, 2026$13.00M–
Q4 FY2025Dec 31, 2025$108.00M-39.0%
Q3 FY2025Sep 30, 2025$219.00M+35.2%
Q2 FY2025Jun 30, 2025$237.00M+18.5%
Q1 FY2025Mar 31, 2025-$4.00M-300.0%
Q4 FY2024Dec 31, 2024$177.00M+12.7%
Q3 FY2024Sep 30, 2024$162.00M-18.2%
Q2 FY2024Jun 30, 2024$200.00M+227.9%
Q1 FY2024Mar 31, 2024$2.00M–
Q4 FY2023Dec 31, 2023$157.00M+1107.7%
Q3 FY2023Sep 30, 2023$198.00M+4.8%
Q2 FY2023Jun 30, 2023$61.00M-80.4%
Q1 FY2023Mar 31, 2023-$145.00M–
Q4 FY2022Dec 31, 2022$13.00M-94.2%
Q3 FY2022Sep 30, 2022$189.00M+112.4%
Q2 FY2022Jun 30, 2022$312.00M+109.4%
Q1 FY2022Mar 31, 2022-$62.00M-381.8%
Q4 FY2021Dec 31, 2021$223.00M–
Q3 FY2021Sep 30, 2021$89.00M–
Q2 FY2021Jun 30, 2021$149.00M-6.9%
Q1 FY2021Mar 31, 2021$22.00M+450.0%
Q4 FY2020Dec 31, 2020-$93.00M-173.7%
Q3 FY2020Sep 30, 2020-$112.00M-382.8%
Q2 FY2020Jun 30, 2020$160.00M+219.4%
Q1 FY2020Mar 31, 2020$4.00M-50.6%
Q4 FY2019Dec 31, 2019$126.20M-9.5%
Q3 FY2019Sep 30, 2019$39.60M-75.8%
Q2 FY2019Jun 30, 2019$50.10M-63.4%
Q1 FY2019Mar 31, 2019$8.10M-82.8%
Q4 FY2018Dec 31, 2018$139.50M+1982.1%
Q3 FY2018Sep 30, 2018$163.90M–
Q2 FY2018Jun 30, 2018$136.90M–
Q1 FY2018Mar 31, 2018$47.00M–
Q4 FY2017Dec 31, 2017$6.70M–

More Elanco Animal Health figures

See a number that looks wrong?